| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228773A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228703A Chelating agents and their metal chelates for treating free radicals induced conditions |
| 09/15/1999 | CN1228694A Method of reducing cardiotoxicity of antitumor agent using manganese compound |
| 09/14/1999 | US5952313 Composition for antagonizing gram negative bacterial endotoxic activity, comprising a pharmaceutically acceptable carrier and an antagonizing amount of a lipopolysaccharide from a rhizobium etli; treatment of septic shock or toxic shock |
| 09/14/1999 | US5952001 Preparing pharmaceutical, dermatological or cosmetic preparations for the prevention or treatment of allergic manifestations such as skin allergy, bronchial asthma, or inflammation, or as free radical scavengers |
| 09/10/1999 | WO1999032514A3 Sag: sensitive to apoptosis gene |
| 09/09/1999 | DE19808192A1 Diisopropylfluorophosphatase sowie deren Verwendung und Herstellung Diisopropyl fluorophosphatase and their use and production |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939766A2 Synthesis of soluble beta-sheet forming peptides |
| 09/08/1999 | EP0939654A1 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 09/08/1999 | EP0939644A1 Enhanced stimulation of erythropoiesis |
| 09/07/1999 | US5948442 Nucleoside, low and high molecular weight peptides, activation of biosynthesis of nucleic aics and specific proteins |
| 09/02/1999 | WO1999043791A2 Diisopropyl fluorophosphatase and the utilization and production thereof |
| 09/02/1999 | WO1999043358A1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors |
| 09/02/1999 | WO1999043345A1 Amino acid degrading enzymes modulate cell death |
| 09/02/1999 | WO1999043303A1 Method for producing encased spherical granular grains |
| 08/26/1999 | WO1999042116A1 Novel disulfides and thiol compounds |
| 08/26/1999 | WO1999042099A1 Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof |
| 08/26/1999 | WO1999042098A1 Small molecules that increase the conversion of food to body weight gain |
| 08/26/1999 | WO1999042097A1 Small molecules that elicit a polarized th1 response and for modulation of cellular immunity |
| 08/26/1999 | WO1999041978A1 Performance enhancement |
| 08/26/1999 | DE19808634A1 Production of pharmaceutical pellets, especially containing iloprost, with stabilized release properties |
| 08/26/1999 | DE19807979A1 New water-soluble dendrimeric fullerene derivatives, useful as neuroprotective and radical scavenging drugs |
| 08/26/1999 | CA2321961A1 Novel disulfides and thiol compounds |
| 08/26/1999 | CA2321814A1 Small molecules that increase the conversion of food to body weight gain |
| 08/25/1999 | EP0937140A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 08/25/1999 | EP0937085A1 Magnesium (-)hydroxycitrate, method of preparation, applications, and compositions in particular pharmaceutical containing same |
| 08/25/1999 | EP0936915A1 Chelating agents and their metal chelates for treating free radicals induced conditions |
| 08/19/1999 | WO1999041283A1 Pf4 fragments and pharmaceutical compositions containing same |
| 08/19/1999 | WO1999032098A3 Combination of a ramba and a tocopherol |
| 08/19/1999 | WO1999016419A9 Perforated microparticles and methods of use |
| 08/19/1999 | WO1999015894A3 Method of identification of leads or active compounds |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/17/1999 | US5939095 At least one parasympathomimetically active substance and at least one parasympatholytically active substance |
| 08/17/1999 | US5938915 Electrolyzing raw water to generate purified proton-rich water in cathode compartment, administering cathode water to patient's blood to reduce oxyanion radicals present in blood |
| 08/11/1999 | EP0934062A1 Antioxidant activity of 3-dehydroshikimates |
| 08/11/1999 | EP0741724B1 Neuroprotective chroman compounds |
| 08/11/1999 | EP0651609B1 Pasteurella multocida toxoid vaccines |
| 08/11/1999 | CN1225631A Bioconjugates of manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysis for dismutating superoxide |
| 08/10/1999 | US5936067 Macrophage inflammatory protein variants |
| 08/05/1999 | WO1999039045A1 Aqueous compositions comprising complexing agents and uses therof |
| 08/05/1999 | WO1999038967A2 Recombinant proteins derived from hgf and msp |
| 08/05/1999 | CA2335037A1 Aqueous compositions comprising complexing agents and uses thereof |
| 08/04/1999 | EP0932410A1 Mistletoe (viscum) extracts |
| 08/03/1999 | US5932623 Process for the production of fruit polyphenols from unripe rosaceae fruit |
| 08/03/1999 | US5932238 Galanthamine containing transdermal applicator for the treatment of alcoholism |
| 08/03/1999 | CA2182101C Neuroprotective compounds |
| 07/29/1999 | WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/28/1999 | EP0931786A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 07/28/1999 | EP0930877A1 Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 07/27/1999 | US5929113 Compositions comprising EMU oil or active fractions thereof and methods of using these compositions as insect repellents |
| 07/27/1999 | US5928926 Isolation and cloning of the human ARSA-I gene and uses thereof |
| 07/27/1999 | US5928921 Nucleotide sequence of enzyme which oxidizes xenobiotics; for evaluating human xenobiotic metabolism in vitro |
| 07/22/1999 | WO1999036076A1 Composition containing propargylamine for enhancing cancer therapy |
| 07/22/1999 | CA2318693A1 Composition containing propargylamine for enhancing cancer therapy |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929232A1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 07/21/1999 | CN1223579A Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 07/21/1999 | CN1223138A Sucrose-free type sweets capable of reducing tobacco toxic and deleterious effect |
| 07/21/1999 | CN1044245C Tricyclic dicarbonyl derivatives, medicinal compositions and use thereof |
| 07/20/1999 | US5925668 Thioctic metabolites and methods of use thereof |
| 07/20/1999 | US5925521 Human serine carboxypeptidase |
| 07/15/1999 | WO1999035247A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/14/1999 | EP0928191A1 Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 07/13/1999 | US5922716 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (ampa) receptor antagonists, non-competitive n-methyl-d-aspartate (nmda) receptor antagonists |
| 07/13/1999 | CA2000153C Antidote |
| 07/08/1999 | WO1999033821A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/06/1999 | US5919816 Administering drug with protective agent |
| 07/06/1999 | US5919451 Feeding the animal feed particles having an inner core of nutrients and an outer layer containing a conjugated fatty acid or an antibody that can protect the animal from contacting diseases that can adversely affect the animal's |
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032131A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 07/01/1999 | WO1999032098A2 Combination of a ramba and a tocopherol |
| 07/01/1999 | CA2303483A1 Sag: sensitive to apoptosis gene |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0924986A1 Antioxidant derived from lentil and its preparation and uses |
| 06/30/1999 | CN1221410A Novel substituted 2,4-thiazolidine diketone derivatives, method for preparation thereof and pharmaceutical compositions containing the same |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1043887C Chemopreventive compound and preparation method and use thereof |
| 06/29/1999 | US5917053 Inhibiting gaba release from neurons |
| 06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
| 06/23/1999 | EP0923371A1 Pharmaceutical compositions comprising tyrphostins |
| 06/22/1999 | US5914095 Polychelants containg amide bonds |
| 06/17/1999 | WO1999029721A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/17/1999 | WO1999029312A1 Methods for treatment of neuro- and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 06/17/1999 | WO1999029294A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 06/17/1999 | WO1999016420A9 Stabilized preparations for use in nebulizers |
| 06/17/1999 | CA2314267A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | CA2311722A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 06/10/1999 | WO1999027953A1 Chemoprotective bacterial strains |
| 06/10/1999 | WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 06/10/1999 | WO1999027801A1 Revitalisation formulation |
| 06/10/1999 | CA2311613A1 Chemoprotective bacterial strains |
| 06/09/1999 | EP0920418A1 Substituted imidazolium salts and their use for the inhibition of protein ageing |
| 06/09/1999 | CN1219104A Method of treating renomous bites and stings |
| 06/09/1999 | CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition |
| 06/08/1999 | US5910311 Inhibiting photoperoxidation of unsaturated lipid by contacting with composition comprising non-photocatalytic metal oxide, tocopherol, metal-inactivating complexing agent |